S'abonner

Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials - 25/08/11

Doi : 10.1016/j.amjmed.2004.01.009 
Rod S Taylor, MSc, PhD a, , Allan Brown, MBA, MA b, Shah Ebrahim, DM, MSc c, Judith Jolliffe, MSc d, Hussein Noorani, MSc b, Karen Rees, MSc, PhD c, Becky Skidmore, MLS b, James A Stone, PhD e, David R Thompson, PhD f, Neil Oldridge, PhD g
a Department of Epidemiology and Public Health (RST), University of Birmingham, Birmingham, United Kingdom 
b Canadian Coordinating Office for Health Technology Assessment (AB, HN, BS), Ottawa, Canada 
c Department of Social Medicine (SE, KR), University of Bristol, Bristol, United Kingdom 
d St. Loye's School of Health Studies (JJ), Exeter, United Kingdom 
e University of Calgary (JAS), Alberta, Canada 
f Chinese University of Hong Kong (DRT), Hong Kong 
g Center for Urban Population Health (NO), University of Wisconsin-Milwaukee, Wisconsin, USA 

*Requests for reprints should be addressed to Rod Taylor, MSc, PhD, Department of Epidemiology and Public Health, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom

Abstract

Purpose

To review the effectiveness of exercise-based cardiac rehabilitation in patients with coronary heart disease.

Methods

A systematic review and meta-analysis of randomized controlled trials was undertaken. Databases such as MEDLINE, EMBASE, and the Cochrane Library were searched up to March 2003. Trials with 6 or more months of follow-up were included if they assessed the effects of exercise training alone or in combination with psychological or educational interventions.

Results

We included 48 trials with a total of 8940 patients. Compared with usual care, cardiac rehabilitation was associated with reduced all-cause mortality (odds ratio [OR] = 0.80; 95% confidence interval [CI]: 0.68 to 0.93) and cardiac mortality (OR = 0.74; 95% CI: 0.61 to 0.96); greater reductions in total cholesterol level (weighted mean difference, –0.37 mmol/L [–14.3 mg/dL]; 95% CI: –0.63 to –0.11 mmol/L [–24.3 to –4.2 mg/dL]), triglyceride level (weighted mean difference, –0.23 mmol/L [–20.4 mg/dL]; 95% CI: –0.39 to –0.07 mmol/L [–34.5 to –6.2 mg/dL]), and systolic blood pressure (weighted mean difference, –3.2 mm Hg; 95% CI: –5.4 to –0.9 mm Hg); and lower rates of self-reported smoking (OR = 0.64; 95% CI: 0.50 to 0.83). There were no significant differences in the rates of nonfatal myocardial infarction and revascularization, and changes in high- and low-density lipoprotein cholesterol levels and diastolic pressure. Health-related quality of life improved to similar levels with cardiac rehabilitation and usual care. The effect of cardiac rehabilitation on total mortality was independent of coronary heart disease diagnosis, type of cardiac rehabilitation, dose of exercise intervention, length of follow-up, trial quality, and trial publication date.

Conclusion

This review confirms the benefits of exercise-based cardiac rehabilitation within the context of today's cardiovascular service provision.

Le texte complet de cet article est disponible en PDF.

Plan


 This study was supported by the Canadian Coordinating Office for Health Technology Assessment, the British Heart Foundation, and the UK Physiotherapy Research Foundation. Dr. Taylor is a former Chair of the British Association of Cardiac Rehabilitation Scientific Committee. Dr. Stone is past president of the Canadian Association of Cardiac Rehabilitation.


© 2004  Excerpta Medica Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 116 - N° 10

P. 682-692 - mai 2004 Retour au numéro
Article précédent Article précédent
  • Familial aggregation of hypertension treatment and control in the genetic epidemiology network of arteriopathy (GENOA) study
  • Paul R Daniels, Sharon L.R Kardia, Craig L Hanis, C.Andrew Brown, Richard Hutchinson, Eric Boerwinkle, Stephen T Turner
| Article suivant Article suivant
  • Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity
  • Neil Smart, Thomas H Marwick

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.